Literature DB >> 30938633

Randomized Controlled Trial of Postoperative Sensitivity with Warm and Room Temperature Composite.

I Campbell1, J Kang2, T P Hyde2.   

Abstract

Physical properties of composite improve when it is preheated prior to polymerization. However, postoperative sensitivity may be considered a potential complication. A review of the literature revealed no reported randomized controlled trials (RCTs) of postoperative sensitivity when using preheated composite resin. The objective of the study was to determine if preheating composite leads to changes in postoperative sensitivity in a parallel RCT. In total, 120 eligible, consenting adults were recruited in private dental practice and randomized into 2 groups of 60 patients. One group had room temperature composite restorations placed and the second had composite preheated to 39°C. The primary outcome was sensitivity after 24 h by the visual analog scale (VAS), recorded blind by patients. Secondary outcomes were VAS scores recorded over a month. Blind statistical analysis used the Mann-Whitney U test to compare the 24-h VAS score between groups and repeated-measures analysis of variance to assess the change over time. Potential confounders were tested using regression models. A total of 115 patients completed the trial: 57 in the heated composite group and 58 in the room temperature group. Analysis of 24-h VAS scores found no statistically significant difference between the 2 groups ( P = 0.162). Examining the potential confounders confirmed the nonsignificant difference between heated and room temperature groups on the 24-h VAS score, after controlling teeth type and preoperative pulp test (effect size = 0.173, P = 0.317). Analysis of the secondary outcomes found significant changes (within-subject effect) in VAS scores over the review period ( F statistic = 4.7, P = 0.002) but not a significant (between-subject effect) difference between heated and room temperature groups over time (effect size = 0.102, P = 0.197). There was a significant correlation between preoperative VAS score and postoperative VAS score ( P < 0.001). For the restorations in this study, there was no detectable difference in postoperative VAS score between preheated and room temperature composite. Postoperative sensitivity decreased throughout the first month. Postoperative sensitivity was correlated to preoperative sensitivity (ISRCTN 76727312). Knowledge Transfer Statement: The results of this study can be used by clinicians when considering the advantages and disadvantages of preheated composite. The study found no evidence of any change in postoperative sensitivity when using preheated composite. Since preheated composite has superior physical properties, its use for routine care can be considered good practice.

Entities:  

Keywords:  composite dental resin; comprehensive dental care; dental caries; dental materials; dentistry; permanent dental restoration

Year:  2016        PMID: 30938633     DOI: 10.1177/2380084416682934

Source DB:  PubMed          Journal:  JDR Clin Trans Res        ISSN: 2380-0844


  3 in total

1.  One-year clinical evaluation of bulk-fill composite resin restorations plasticized by preheating and ultrasonics: A randomized clinical trial.

Authors:  Girija S Sajjan; Gnana Sindhu Dutta; K Madhu Varma; R Kalyan Satish; Anil Kumar Pulidindi; Vishal Babu Kolla
Journal:  J Conserv Dent       Date:  2022-05-02

2.  Eighteen-month clinical performance of preheated nanoceramic resin-based composites in Class I occlusal cavities: A randomized clinical trial.

Authors:  Neha Taufin; Bollu Indira Priyadarshini; Pushpa Shankarappa; Srinidhi Vishnu Ballullaya; Srihari Devalla; Snigdha Gavini
Journal:  J Conserv Dent       Date:  2022-05-02

Review 3.  Compliance of randomized controlled trials in posterior restorations with the CONSORT statement: a systematic review of methodology.

Authors:  Márcia Rezende; Ana Cristina Rodrigues Martins; Jadson Araújo da Silva; Alessandra Reis; Juliana Larocca de Geus
Journal:  Clin Oral Investig       Date:  2021-09-30       Impact factor: 3.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.